Evidence map›Paper›PMID 35577075›Full record

ArticleThe Journal of biological chemistry2022

Prolonged deprivation of arginine or leucine induces PI3K/Akt-dependent reactivation of mTORC1.

Gwen R Buel, Huy Q Dang, John M Asara, John Blenis, Anders P Mutvei

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Gwen R BuelPrograms in Biological and Biomedical Sciences, Harvard Medical School, Boston, Massachusetts, USA; Meyer Cancer Center and Department of Pharmacology, Weill Cornell Medical College, New York, New York, USA; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.
Huy Q DangDepartment of Immunology, Pathology and Genetics, Uppsala University, Uppsala, Sweden.
John M AsaraDepartment of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
John BlenisMeyer Cancer Center and Department of Pharmacology, Weill Cornell Medical College, New York, New York, USA; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: jblenis@med.cornell.edu.
Anders P MutveiDepartment of Immunology, Pathology and Genetics, Uppsala University, Uppsala, Sweden. Electronic address: anders.mutvei@igp.uu.se.
Harvard University · USUppsala University · SEBeth Israel Deaconess Medical Center · US

Funding

SIGNAL TRANSDUCTION TO PP70 S6KR01GM051405 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI BLENIS, JOHN · 1995 to 2023
$14.0M
mTORC1 Regulation by Amino AcidsF31CA173942 · NCI · HARVARD MEDICAL SCHOOL · PI BUEL, GWEN R · 2013 to 2015
$94k
NCI NIH HHS F31 CA173942NIGMS NIH HHS R01 GM051405
6 · The paper itself

Abstract

The mechanistic target of rapamycin complex 1 (mTORC1) is a serine/threonine kinase complex that promotes anabolic processes including protein, lipid, and nucleotide synthesis, while suppressing catabolic processes such as macroautophagy. mTORC1 activity is regulated by growth factors and amino acids, which signal through distinct but integrated molecular pathways: growth factors largely signal through the PI3K/Akt-dependent pathway, whereas the availabilities of amino acids leucine and arginine are communicated to mTORC1 by the Rag-GTPase pathway. While it is relatively well described how acute changes in leucine and arginine levels affect mTORC1 signaling, the effects of prolonged amino acid deprivation remain less well understood. Here, we demonstrate that prolonged deprivation of arginine and/or leucine leads to reactivation of mTORC1 activity, which reaches activation levels similar to those observed in nutrient-rich conditions. Surprisingly, we find that this reactivation is independent of the regeneration of amino acids by canonical autophagy or proteasomal degradation but is dependent on PI3K/Akt signaling. Together, our data identify a novel crosstalk between the amino acid and PI3K/Akt signaling pathways upstream of mTORC1. These observations extend our understanding of the role of mTORC1 in growth-related diseases and indicate that dietary intervention by removal of leucine and/or arginine may be an ineffective therapeutic approach.

Indexed as

Mechanistic Target of Rapamycin Complex 1Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktAmino AcidsAnimalsArginineLeucineMiceAmino AcidsArginineLeucineMechanistic Target of Rapamycin Complex 1Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktAktamino acidmTORC1signalingstarvation

Identifiers

PMID35577075
PMCPMC9194872
OpenAlexW4280515880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.